NEW MJ NEWS

Cara Therapeutics to Present at the Canaccord Genuity 43rd Annual Growth Conference

Cara Therapeutics, Inc. (Nasdaq: CARA), a commercial-stage biopharmaceutical company leading a new treatment paradigm to improve the lives of patients suffering from pruritus, today announced that Christopher Posner, President and Chief Executive Officer, will present at the Canaccord Genuity 43rd Annual Growth Conference on Wednesday, August 9, 2023, at 8:00 a.m. EDT in Boston, MA.

A webcast of the presentation can be accessed under “Events & Presentations” in the Investors section of the Company’s website at www.CaraTherapeutics.com. An archived webcast recording will be available on the Cara website for approximately 30 days.

About Cara Therapeutics

Cara Therapeutics is a commercial-stage biopharmaceutical company leading a new treatment paradigm to improve the lives of patients suffering from pruritus. The Company’s KORSUVA® (difelikefalin) injection is the first and only FDA-approved treatment for moderate-to-severe pruritus associated with chronic kidney disease in adults undergoing hemodialysis. The Company is developing an oral formulation of difelikefalin and has Phase 3 programs ongoing for the treatment of pruritus in patients with advanced chronic kidney disease and atopic dermatitis. In addition, the Company has initiated a Phase 2/3 program of oral difelikefalin for the treatment of moderate-to-severe pruritus in patients with notalgia paresthetica. For more information, visit www.CaraTherapeutics.com and follow the company on Twitter, LinkedIn and Instagram.

MEDIA CONTACT:
Annie Spinetta
6 Degrees
973-768-2170
aspinetta@6degreespr.com

INVESTOR CONTACT:
Iris Francesconi, Ph.D.
Cara Therapeutics
203-406-3700
investor@caratherapeutics.com


MAPH Enterprises, LLC | (305) 414-0128 | 1501 Venera Ave, Coral Gables, FL 33146 | new@marijuanastocks.com
Leave a Reply

Your email address will not be published. Required fields are marked *

You May Also Like

$PLPL Gives End of the Year Update

Plandai Biotechnology, Inc. Provides Year-End Shareholder Update LOGAN, UT–(Marketwired – December 31,…

$MDBX Under Investigation by Kirby McInerney

Law Firm Kirby McInerney LLP Investigating Potential Claims on Behalf of Medbox,…

Tauriga Sciences, Inc. (TAUG) Now Shipping its CBD Infused Chewing Gum from its Fulfillment Facility!

Tauriga Sciences Inc. Now Shipping its CBD Infused Chewing Gum from its…

Cronos Group Inc. (CRON) Reports 2021 Third Quarter Results

Cronos Group Reports 2021 Third Quarter Results Cronos Group Inc. (NASDAQ: CRON)…